Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharma Group Ltd, Capital House, 85 King William Street, London, EC4N 7BL, UK
Fersamal 322mg tablets.
Ferrous Fumarate 322mg Film-Coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated Tablets. Each film coated tablet is brown ochre in colour and engraved ‘FE’ on one face and ‘322’ on the other. |
Each tablet contains 322.0mg Ferrous Fumarate BP (equivalent to approximately 100 mg ferrous iron).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ferrous fumarate |
Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias. |
| List of Excipients |
|---|
|
Tablet core: Maize Starch BP Film coating: Acetylated Monoglyceride Opadry20A270006 contains: Hypromellose |
Cartons containing two blister packs of 14 tablets, prepared from White 250/60 micron PVC/PVDC film and printed 30 micron hard-tempered aluminium foil. 28 tablets in each carton or dispensing pack of 1000 tablets in Polypropylene container with tamper evident low density polyethylene cap.
Mercury Pharma Group Ltd, Capital House, 85 King William Street, London, EC4N 7BL, UK
PL 10972/0041
07/01/2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
